Cancer Risk Assessment in Precision Medicine
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Omics/Informatics".
Deadline for manuscript submissions: 25 July 2025 | Viewed by 51
Special Issue Editor
Interests: cancer risk assessment; public health; cancer epidemiology; evidence based medicine; gynecologic oncology; meta-analysis
Special Issue Information
Dear Colleagues,
Cancer continues to be a significant public health concern, affecting millions of individuals worldwide. As the incidence of cancer continues to rise, understanding the risk factors and implementing effective prevention strategies becomes of paramount importance. Assessment of the risk factors for developing a specific cancer is of invaluable help for designing strategies that attempt to increase early detection. Therefore, a better understanding of who may be at increased risk, and the factors that contribute to this risk is necessary to improve cancer detection at earlier stages.
This Special Issue aims to provide a comprehensive platform for researchers, clinicians, and public health experts to share their latest findings, innovative approaches, and evidence-based interventions in the field of cancer risk assessment. I invite authors to contribute original research papers, systematic reviews, meta-analyses, and perspectives that delve into various aspects of cancer risk assessment.
Dr. Agnieszka Drab
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer risk
- public health
- cancer epidemiology
- risk factors
- cancer incidence
- cancer prevalence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
